Your browser doesn't support javascript.
loading
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Tang, Yan; Liu, Wei; Kadu, Siddhant; Johnson, Omar; Hasanali, Zainul S; Kelly, Andre; Shestov, Alexander; Pajarillo, Raymone; Greenblatt, Eli; Holmes, Matthew; Wang, Li-Ping; Shih, Natalie; O'Connor, Roddy S; Ruella, Marco; Garfall, Alfred L; Allman, David; Vogl, Dan T; Cohen, Adam; June, Carl H; Sheppard, Neil C.
Affiliation
  • Tang Y; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Liu W; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Kadu S; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Johnson O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Hasanali ZS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kelly A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Shestov A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Pajarillo R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Greenblatt E; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Holmes M; IsoPlexis, Bradford, CT.
  • Wang LP; IsoPlexis, Bradford, CT.
  • Shih N; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • O'Connor RS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Ruella M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA.
  • Garfall AL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Allman D; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Vogl DT; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Cohen A; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • June CH; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Sheppard NC; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Blood ; 143(2): 139-151, 2024 Jan 11.
Article in En | MEDLINE | ID: mdl-37616575
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunotherapy, Adoptive / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunotherapy, Adoptive / Multiple Myeloma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2024 Type: Article